Calamos Wealth Management LLC Has $13.41 Million Stock Position in Stryker Corporation $SYK

Calamos Wealth Management LLC boosted its holdings in Stryker Corporation (NYSE:SYK) by 4.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,269 shares of the medical technology company’s stock after purchasing an additional 1,448 shares during the period. Calamos Wealth Management LLC’s holdings in Stryker were worth $13,408,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of the business. Mid American Wealth Advisory Group Inc. acquired a new stake in shares of Stryker in the second quarter valued at about $26,000. Clayton Financial Group LLC acquired a new position in shares of Stryker during the 3rd quarter worth approximately $26,000. Elevation Point Wealth Partners LLC bought a new stake in shares of Stryker during the 2nd quarter worth approximately $28,000. Sachetta LLC boosted its holdings in shares of Stryker by 58.7% in the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock valued at $29,000 after buying an additional 27 shares during the last quarter. Finally, Kilter Group LLC bought a new position in shares of Stryker in the second quarter valued at $29,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

SYK has been the subject of a number of recent analyst reports. Wall Street Zen upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research note on Sunday, December 21st. BTIG Research reaffirmed a “buy” rating and issued a $410.00 target price on shares of Stryker in a report on Friday, November 14th. Rothschild Redb upgraded Stryker to a “hold” rating in a report on Thursday, September 18th. Redburn Partners set a $420.00 price objective on Stryker in a research note on Thursday, September 18th. Finally, Wells Fargo & Company lifted their target price on Stryker from $452.00 to $456.00 and gave the stock an “overweight” rating in a research note on Friday, November 14th. Thirteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $431.84.

Insider Buying and Selling

In other news, CFO Preston Wendell Wells sold 165 shares of the firm’s stock in a transaction that occurred on Thursday, November 20th. The shares were sold at an average price of $365.88, for a total transaction of $60,370.20. Following the transaction, the chief financial officer directly owned 6,694 shares of the company’s stock, valued at approximately $2,449,200.72. This trade represents a 2.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Ronda E. Stryker sold 276,173 shares of the business’s stock in a transaction that occurred on Thursday, November 6th. The shares were sold at an average price of $353.28, for a total value of $97,566,397.44. Following the completion of the sale, the director owned 2,702,108 shares of the company’s stock, valued at approximately $954,600,714.24. This trade represents a 9.27% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 522,118 shares of company stock valued at $185,381,932. 5.20% of the stock is owned by company insiders.

Stryker Trading Up 0.5%

Shares of NYSE:SYK opened at $354.20 on Wednesday. Stryker Corporation has a 12-month low of $329.16 and a 12-month high of $406.19. The business has a 50 day moving average of $362.68 and a 200-day moving average of $376.10. The company has a quick ratio of 1.13, a current ratio of 1.85 and a debt-to-equity ratio of 0.68. The stock has a market cap of $135.45 billion, a PE ratio of 46.54, a P/E/G ratio of 2.50 and a beta of 0.89.

Stryker (NYSE:SYK) last released its quarterly earnings results on Friday, October 31st. The medical technology company reported $3.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.13 by $0.06. Stryker had a return on equity of 24.07% and a net margin of 12.07%.The business had revenue of $6.06 billion during the quarter, compared to the consensus estimate of $6.04 billion. During the same period in the previous year, the company posted $2.87 EPS. The firm’s quarterly revenue was up 10.2% on a year-over-year basis. As a group, equities research analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be paid a $0.88 dividend. This represents a $3.52 annualized dividend and a dividend yield of 1.0%. This is a boost from Stryker’s previous quarterly dividend of $0.84. The ex-dividend date is Wednesday, December 31st. Stryker’s dividend payout ratio is currently 44.15%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.